VLP the Vaccines Company
PrivateLast Round
Grant
Jan 1, 2019
Company Overview
VLP the Vaccines Company operates in Healthcare & Life Sciences and is based in Boecillo. Its latest recorded funding round was a Grant round in January 2019.
VLP the Vaccines Company is a biotechnology company that develops immunotherapeutic solutions for human and animal health using a proprietary chimeric virus-like particle (VLP) technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VLP the Vaccines Company Comparables
Compare VLP the Vaccines Company with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VLP Therapeutics | 84% | |
| Iaso Therapeutics | 84% | |
| AdaptVac | 84% |
For institutional investors. Book with your work email.
VLP the Vaccines Company Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2019 | ||||
| VC Round | Feb 16, 2018 | ||||
| Grant | Jul 1, 2017 |
For institutional investors. Book with your work email.
VLP the Vaccines Company Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inveready | VC Round |
| European Union's Horizon 2020 | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2019
Received funding from the European Union's Horizon 2020 program.
For institutional investors. Book with your work email.
VLP the Vaccines Company Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VLP the Vaccines Company's valuation, stock price, and market status.
Is VLP the Vaccines Company a public or private company?
VLP the Vaccines Company is a private company.
What is the current stock price of VLP the Vaccines Company?
VLP the Vaccines Company is a private company, so its shares have no public market price. Caplight tracks VLP the Vaccines Company's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VLP the Vaccines Company worth (valuation)?
Valuation information for VLP the Vaccines Company is not publicly available.
Can I buy VLP the Vaccines Company stock?
VLP the Vaccines Company shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VLP the Vaccines Company's last funding round?
VLP the Vaccines Company's most recent funding round was Grant on January 1, 2019.
Who are the main investors in VLP the Vaccines Company?
Key investors in VLP the Vaccines Company include Inveready.
Will VLP the Vaccines Company IPO soon?
No public IPO plans have been announced for VLP the Vaccines Company.
How can I track VLP the Vaccines Company secondary market activity?
Caplight tracks bids, offers, and trades in VLP the Vaccines Company's shares on secondary markets.